IES Diagnostics Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $140K
Latest Deal Amount

IES Diagnostics General Information

Description

Provider of molecular diagnostic tests. The company produces rapid diagnostic tools, specifically for Ebola, cancer, and autoimmune and viral diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 175 Strafford Avenue
  • Wayne, PA 19087
  • United States
+1 (267) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IES Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 30-Mar-2015 $140K 00000 Completed Startup
2. Equity Crowdfunding 16-Mar-2015 0000.00 0000.00 Completed Startup
1. Equity Crowdfunding Completed Startup
To view IES Diagnostics’s complete valuation and funding history, request access »

IES Diagnostics Executive Team (2)

Name Title Board Seat Contact Info
David Spiegel Chief Executive Officer & Chairman
Ronald Jubin Ph.D Founder, President, & Board Member
To view IES Diagnostics’s complete executive team members history, request access »

IES Diagnostics Board Members (1)

Name Representing Role Since
David Spiegel IES Diagnostics Chief Executive Officer & Chairman 000 0000
To view IES Diagnostics’s complete board members history, request access »

IES Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial